ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Eagle Pharmaceuticals Inc

Eagle Pharmaceuticals Inc (EGRX)

2,14
0,00
(0,00%)
Fermé 04 Février 10:00PM
0,00
0,00
(0,00%)
Après les heures de négociation: -

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

Dernier
2,14
Prix Achat
2,27
Prix Vente
2,30
Volume échangé
-
0,00 Fourchette du Jour 0,00
1,80 Plage de 52 semaines 6,81
Cap du marché
Clôture Veille
2,14
Ouverture
-
Dernière Transaction
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
-
Actions en circulation
12 986 971
Rendement du Dividende
-
Ratio Cours sur Bénéfices
0,78
Bénéfice par action (BPA)
2,74
Chiffre d'affairess
316,61M
Bénéfice net
35,64M

À propos de Eagle Pharmaceuticals Inc

Eagle Pharmaceuticals Inc is a specialty pharmaceutical company. The company develops and commercializes injectable products in the areas of critical care, orphan diseases, and oncology. Its product portfolio consists of four approved products: Argatroban, Ryanodex, Belrapzo, and Bendeka. The compan... Eagle Pharmaceuticals Inc is a specialty pharmaceutical company. The company develops and commercializes injectable products in the areas of critical care, orphan diseases, and oncology. Its product portfolio consists of four approved products: Argatroban, Ryanodex, Belrapzo, and Bendeka. The company currently has multiple product candidates in advanced stages of development and is under review for approval by the Food and Drug Administration. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
Siège social
Wilmington, Delaware, USA
Fondé
-
Eagle Pharmaceuticals Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker EGRX. Le dernier cours de clôture d'Eagle Pharmaceuticals était de US$2,14. Au cours de la dernière année, les actions de Eagle Pharmaceuticals ont été négociées dans une fourchette de prix de US$ 1,80 à US$ 6,81.

Eagle Pharmaceuticals compte actuellement 12 986 971 actions en circulation. La capitalisation boursière d'Eagle Pharmaceuticals est de US$27,79 million. Eagle Pharmaceuticals a un ratio cours/bénéfice (ratio PE) de 0.78.

EGRX Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1002.142.142.1400CS
4002.142.142.1400CS
12002.142.142.1400CS
26-2.32-52.01793721974.465.451.8674873.08785283CS
52-3.63-62.91161178515.776.811.81194684.50506569CS
156-42.64-95.221080839744.7853.781.815196720.25418826CS
260-51.7-96.025260029753.8459.1151.814540630.15066279CS

EGRX - Frequently Asked Questions (FAQ)

What is the current Eagle Pharmaceuticals share price?
The current share price of Eagle Pharmaceuticals is US$ 2,14
How many Eagle Pharmaceuticals shares are in issue?
Eagle Pharmaceuticals has 12 986 971 shares in issue
What is the market cap of Eagle Pharmaceuticals?
The market capitalisation of Eagle Pharmaceuticals is USD 27,79M
What is the 1 year trading range for Eagle Pharmaceuticals share price?
Eagle Pharmaceuticals has traded in the range of US$ 1,80 to US$ 6,81 during the past year
What is the PE ratio of Eagle Pharmaceuticals?
The price to earnings ratio of Eagle Pharmaceuticals is 0,78
What is the cash to sales ratio of Eagle Pharmaceuticals?
The cash to sales ratio of Eagle Pharmaceuticals is 0,09
What is the reporting currency for Eagle Pharmaceuticals?
Eagle Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Eagle Pharmaceuticals?
The latest annual turnover of Eagle Pharmaceuticals is USD 316,61M
What is the latest annual profit for Eagle Pharmaceuticals?
The latest annual profit of Eagle Pharmaceuticals is USD 35,64M
What is the registered address of Eagle Pharmaceuticals?
The registered address for Eagle Pharmaceuticals is CORPORATION TRUST CENTER, 1209 ORANGE ST, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Eagle Pharmaceuticals website address?
The website address for Eagle Pharmaceuticals is www.eagleus.com
Which industry sector does Eagle Pharmaceuticals operate in?
Eagle Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
IVVDInvivyd Inc
US$ 1,055
(194,94%)
448,53M
HCWBHCW Biologics Inc
US$ 0,6265
(125,20%)
344,42M
UOKAMDJM Ltd
US$ 0,2293
(76,38%)
354,09M
GHRSGH Research PLC
US$ 17,9991
(69,80%)
10,31M
WHLRLWheeler Real Estate Investment Trust Inc
US$ 234,64
(61,82%)
392
CYNCYNGN Inc
US$ 0,1169
(-56,70%)
75,52M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,1943
(-54,61%)
327,95M
VIRXViracta Therapeutics Inc
US$ 0,0741
(-51,09%)
9,37M
BOWNUBowen Acquisition Corporation
US$ 3,39
(-49,55%)
17,28k
PITAHeramba Electric PLC
US$ 0,503
(-44,11%)
1,37M
IVVDInvivyd Inc
US$ 1,055
(194,94%)
448,53M
BHATBlue Hat Interactive Entertainment Technology
US$ 0,0462
(27,98%)
434,24M
NVDANVIDIA Corporation
US$ 116,66
(-2,84%)
371,47M
UOKAMDJM Ltd
US$ 0,2293
(76,38%)
354,09M
HCWBHCW Biologics Inc
US$ 0,6265
(125,20%)
344,42M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées